composites against staphylococcus aureus atcc 25923 (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
99
Structured Review
ATCC
composites against staphylococcus aureus atcc 25923
Composites Against Staphylococcus Aureus Atcc 25923, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 34575 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/composites+against+staphylococcus+aureus+atcc+25923/Staphylococcus+aureus+subsp%2E+aureus+Rosenbach/pm39965699-98-6-10
Average 99 stars, based on 34575 article reviews
Composites Against Staphylococcus Aureus Atcc 25923, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 34575 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/composites+against+staphylococcus+aureus+atcc+25923/Staphylococcus+aureus+subsp%2E+aureus+Rosenbach/pm39965699-98-6-10
Average 99 stars, based on 34575 article reviews
composites against staphylococcus aureus atcc 25923 - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
Activity Assay:Article Title: High-load, sustained-release antibacterial composite particles based on modified vaterite coated with quaternary ammonium chitosan and aldehyde hyaluronic acid for controlled drug delivery systems. Article Snippet: Porous vaterite particles exhibit good biocompatibility, degradability, and favorable physical and chemical properties, making them promising candidates for drug carriers.. However, challenges such as low loading capacity, burst release effect and limited antibacterial properties hinder their practical applications.. Herein, submicron vaterite particles were synthesized at low temperature and modified by stearic acid, and the resulting modified vaterite particles (Vc) possess exceptional loading capacity towards a typical anticancer drug — doxorubicin. |